Regulation of the Molecular Brake Region in FGFR2 Kinase

被引：0
|
作者：
Karp, Jerome M. [1 ]
Cowburn, David [1 ]
机构：
[1] Yeshiva Univ, Albert Einstein Coll Med, Biochem, Bronx, NY USA
来源：
BIOPHYSICAL JOURNAL | 2015年 / 108卷 / 02期
关键词：
D O I：
10.1016/j.bpj.2014.11.2907
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
2684-Pos
引用
收藏
页码：530A / 530A
页数：1
相关论文
共 50 条
  • [1] Regulation of the "molecular brake" region in FGFR2 kinase.
    Karp, J. M.
    Cowburn, D.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [2] In vivo characterization of a selective FGFR2 inhibitor with potency against gatekeeper and molecular brake mutations
    Fischer, John
    Bouhana, Karyn
    Chicarelli, Mark
    Fell, Brad
    Fulton, Jennifer
    Guarnieri, Anna
    Haygood, Leyla
    Jalluri, Ravi
    Johnson, Amber
    Mclean, Brent
    Mejia, Max
    Rieger, Rob
    Robinson, John
    Rodriguez, Mareli
    Sullivan, Francis
    Wang, Yang
    Winski, Shannon
    Zhou, YeYun
    CANCER RESEARCH, 2023, 83 (07)
  • [3] TYRA-200: Potent Against FGFR2 Fusions, Molecular Brake Mutations and Gatekeeper Resistance
    Allen, E.
    Balcer, A.
    Bensen, D.
    Burn, T.
    Hoffman, I.
    Hudkins, R.
    Iyer, S.
    Neal, M.
    Nelson, K.
    Occhino, C.
    Patel, P.
    Starrett, J.
    Swanson, R.
    Ye, Q.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S16 - S16
  • [4] FGFR2 as a molecular target in endometrial cancer
    Byron, Sara A.
    Pollock, Pamela M.
    FUTURE ONCOLOGY, 2009, 5 (01) : 27 - 32
  • [5] Identification of a reversible selective FGFR2 clinical development candidate with potency against gatekeeper and molecular brake mutations
    Fischer, John
    Bouhana, Karyn
    Brizendine, Richard
    Chicarelli, Mark
    Fell, Brad
    Fulton, Jennifer
    Guarnieri, Anna
    Haygood, Leyla
    Jalluri, Ravi
    Johnson, Amber
    Koch, Keith
    Koslov-Davino, Erika
    Mejia, Max
    Rieger, Rob
    Robinson, John
    Rodriguez, Mareli
    Sullivan, Francis
    Wang, Yang
    Winski, Shannon
    Wood, Silas
    Zhou, Yeyun
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [6] ctDNA-based genomic landscape analysis to evaluate molecular brake and gatekeeper mutations in FGFR2 alterations
    Severson, Paul
    Sytnikova, Julia
    Mohan, Adithi
    Zhang, Nicole
    Donderici, Elifnur Yay
    Williams, Richard Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
    Balasooriya, Eranga R.
    Wu, Qibiao
    Ellis, Haley
    Zhen, Yuanli
    Norden, Bryanna L.
    Corcoran, Ryan B.
    Mohan, Adithi
    Martin, Eric
    Franovic, Aleksandra
    Tyhonas, John
    Lardy, Matthew
    Grandinetti, Kathryn B.
    Pelham, Robert
    Soroceanu, Liliana
    Silveira, Vanessa S.
    Bardeesy, Nabeel
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2181 - 2192
  • [8] Investigation of G-quadruplex formation in the FGFR2 promoter region and its transcriptional regulation by liensinine
    Zhang, Lulu
    Tan, Wei
    Zhou, Jiang
    Xu, Ming
    Yuan, Gu
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (04): : 884 - 891
  • [9] Effects of FGFR2 kinase activation loop dynamics on catalytic activity
    Karp, Jerome M.
    Sparks, Samuel
    Cowburn, David
    PLOS COMPUTATIONAL BIOLOGY, 2017, 13 (02)
  • [10] The combined action of the intracellular regions regulates FGFR2 kinase activity
    Lin, Chi-Chuan
    Wieteska, Lukasz
    Poncet-Montange, Guillaume
    Suen, Kin Man
    Arold, Stefan T.
    Ahmed, Zamal
    Ladbury, John E.
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
12345